| http://www.w3.org/ns/prov#value | - But I think the risk to our patients with aggressive forms of MS or people who aren???t responding to therapies or who are intolerant of therapies and really not taking the drugs - they are not compliant - I think the risk to them is MS. And I think the risk of Tysabri is far less than the risk that MS poses as far as their progression of disease and disability.
|
